Related Experiment Video
Updated: May 9, 2025

A Protocol for Comprehensive Assessment of Bulbar Dysfunction in Amyotrophic Lateral Sclerosis ALS
Published on: February 21, 2011
Speech Differences between Multiple System Atrophy and Parkinson's Disease.
Tom Hähnel1, Anna Nemitz1, Katja Schön2
1Department of Neurology, Medical Faculty and University Hospital Carl Gustav Carus, TUD - Dresden University of Technology, Dresden, Germany.
Speech analysis can differentiate multiple system atrophy (MSA) from Parkinson's disease (PD). Distinct speech patterns in MSA, including pauses and rhythm irregularities, provide a reliable digital biomarker for early diagnosis.
Area of Science:
- Neurology
- Speech-Language Pathology
- Biomarker Discovery
Background:
- Distinguishing early Parkinson's disease (PD) from multiple system atrophy (MSA) is clinically challenging.
- Speech characteristics are recognized digital biomarkers for PD and ataxia, but data for MSA is scarce.
Purpose of the Study:
- To investigate the utility of speech characteristics as a digital biomarker for differentiating MSA from PD.
- To assess if speech analysis can aid in early diagnosis of neurodegenerative conditions.
Main Methods:
- Speech assessments including text reading, sustained phonation, and diadochokinetic tasks were performed on 21 MSA and 23 PD patients.
- Speech features were extracted using Praat software for detailed acoustic analysis.
Main Results:
- Three key speech factors differentiated MSA and PD.
- MSA speech showed increased reading pauses, pitch variability, syllable duration, and irregular rhythm (ROC-AUC 0.89).
- Speech characteristics correlated significantly with motor impairment and overall disease severity.
Conclusions:
- Speech analysis accurately differentiates MSA from PD.
- Speech patterns offer a promising, non-invasive digital biomarker for early differential diagnosis in neurodegenerative diseases.
More Related Videos
11:00Targeted Training of Ultrasonic Vocalizations in Aged and Parkinsonian Rats
Published on: August 8, 2011
07:26Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
Published on: September 26, 2019
Related Concept Videos
Parkinson's Disease: Overview
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Neural Regulation
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...